Identification of activators of ERK5 transcriptional activity by high-throughput screening and the role of endothelial ERK5 in vasoprotective effects induced by statins and antimalarial agents
about
Endothelial Plasticity: Shifting Phenotypes through Force FeedbackEndothelial protective genes induced by statin are mimicked by ERK5 activation as triggered by a drug combination of FTI-277 and GGTI-298.Hydroxychloroquine Protects against Cardiac Ischaemia/Reperfusion Injury In Vivo via Enhancement of ERK1/2 PhosphorylationEndothelial Cell Dysfunction and the Pathobiology of AtherosclerosisThe Vitamin E Analog Gamma-Tocotrienol (GT3) and Statins Synergistically Up-Regulate Endothelial Thrombomodulin (TM).Absence of ERK5/MAPK7 delays tumorigenesis in Atm-/- mice.Statin regulated ERK5 stimulates tight junction formation and reduces permeability in human cardiac endothelial cells.Rheumatoid Arthritis Pharmacotherapies: Do They Have Anti-Atherosclerotic Activity?Extracellular signal-regulated kinase 5 promotes acute cellular and systemic inflammation.Dipeptidyl Peptidase-4 Inhibitor Anagliptin Prevents Intracranial Aneurysm Growth by Suppressing Macrophage Infiltration and Activation.Identification of potential target genes for ankylosing spondylitis treatment.Krüppel-Like Factors in Vascular Inflammation: Mechanistic Insights and Therapeutic Potential.Endothelial Myocyte Enhancer Factor 2c Inhibits Migration of Smooth Muscle Cells Through Fenestrations in the Internal Elastic Lamina.Rosuvastatin Inhibits Interleukin (IL)-8 and IL-6 Production in Human Coronary Artery Endothelial Cells Stimulated With Aggregatibacter actinomycetemcomitans Serotype b.Network-based approach to prediction and population-based validation of in silico drug repurposing.Ponatinib Activates an Inflammatory Response in Endothelial Cells via ERK5 SUMOylation
P2860
Q26767430-B42E359B-07ED-4096-8FF4-4F2848A88CCFQ35736398-D82D9CB7-775B-411E-90B6-208CB4AA56A8Q35860938-0281B700-92F4-41EB-B09C-9F0BB478C5CBQ36602763-2F7E6C3C-7E55-40A0-ACDA-C4F071FAEF78Q37465740-F0027A42-1E8A-48E3-BAB6-36D9257380D7Q37688789-845D6AB6-A41D-436D-A750-2A8092C759F3Q38714493-A9EB85A9-E3EE-48F2-8266-A9520030D84BQ38794852-81AB2271-5CD6-4E11-A46B-C11E4D2D02DFQ41033728-CED98D5F-6279-4FBF-9133-50DB18DCC5ACQ43163467-EB50F971-E94C-4D73-AFAE-05F63D9D9382Q49712215-4A8BDA85-D650-492B-BE79-07E8AE5A9C3AQ49828837-6C8BCC38-138E-4818-B515-416BD9B86FEDQ50672440-31BC965A-F913-43FC-81F4-D4869BAB67DEQ51395005-1707F7BD-42DA-4271-86E9-43B9EFD545EAQ55643995-3AD66E2F-E96A-4C33-B08E-7399642810D2Q58761411-EA82482D-F7DC-4590-A568-E9CB9FD1B660
P2860
Identification of activators of ERK5 transcriptional activity by high-throughput screening and the role of endothelial ERK5 in vasoprotective effects induced by statins and antimalarial agents
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Identification of activators o ...... tatins and antimalarial agents
@ast
Identification of activators o ...... tatins and antimalarial agents
@en
Identification of activators o ...... tatins and antimalarial agents
@nl
type
label
Identification of activators o ...... tatins and antimalarial agents
@ast
Identification of activators o ...... tatins and antimalarial agents
@en
Identification of activators o ...... tatins and antimalarial agents
@nl
prefLabel
Identification of activators o ...... tatins and antimalarial agents
@ast
Identification of activators o ...... tatins and antimalarial agents
@en
Identification of activators o ...... tatins and antimalarial agents
@nl
P2093
P2860
P356
P1476
Identification of activators o ...... tatins and antimalarial agents
@en
P2093
Alan V Smrcka
Craig Morrell
Hakjoo Lee
Jun-ichi Abe
Keigi Fujiwara
Kyung Ae Ko
Masashi Akaike
Nhat-Tu Le
Yuichiro Takei
P2860
P304
P356
10.4049/JIMMUNOL.1400571
P407
P577
2014-09-03T00:00:00Z